» Articles » PMID: 1496620

Significance of a Positive Crossmatch on Outcome in Human Liver Transplantation

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1992 Aug 1
PMID 1496620
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

What's new in clinical solid organ transplantation by 2013.

Salvadori M, Bertoni E World J Transplant. 2014; 4(4):243-66.

PMID: 25540734 PMC: 4274595. DOI: 10.5500/wjt.v4.i4.243.


Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.

OLeary J, Kaneku H, Demetris A, Marr J, Shiller S, Susskind B Liver Transpl. 2014; 20(2):218-27.

PMID: 24382837 PMC: 4623588. DOI: 10.1002/lt.23788.


De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.

Kaneku H, OLeary J, Banuelos N, Jennings L, Susskind B, Klintmalm G Am J Transplant. 2013; 13(6):1541-8.

PMID: 23721554 PMC: 4408873. DOI: 10.1002/ajt.12212.


Class II alloantibody and mortality in simultaneous liver-kidney transplantation.

OLeary J, Gebel H, Ruiz R, Bray R, Marr J, Zhou X Am J Transplant. 2013; 13(4):954-960.

PMID: 23433356 PMC: 4412610. DOI: 10.1111/ajt.12147.


High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

OLeary J, Kaneku H, Susskind B, Jennings L, Neri M, Davis G Am J Transplant. 2011; 11(9):1868-76.

PMID: 21672151 PMC: 4412604. DOI: 10.1111/j.1600-6143.2011.03593.x.